Login / Signup

Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study.

Hannes S KettnerLeor RosemanAdam GazzaleyRobin Carhart-HarrisLorenzo Pasquini
Published in: Research square (2024)
Affective symptoms such as anxiety, low mood, and loneliness are prevalent and highly debilitating symptoms among older adults (OA). Serotonergic psychedelics are novel experimental interventions for affective disorders, yet little is known regarding their effects in OA. Using a prospective cohort design, we identified 62 OA (age ≥ 60 years) and 62 matched younger adults (YA) who completed surveys two weeks before, and one day, two weeks, four weeks, and six months after a guided psychedelic group session in a retreat setting. Mixed linear regression analyses revealed significant well-being improvements in OA and YA, amplified in OA with a history of a psychiatric diagnosis. Compared to YA, acute subjective psychedelic effects were attenuated in OA and did not significantly predict well-being changes. However, a psychosocial measure of Communitas emerged as a predictor in OA, suggesting that the relational components in psychedelic group settings may hold particular value for OA.
Keyphrases
  • knee osteoarthritis
  • sleep quality
  • bipolar disorder
  • mental health
  • social support
  • gestational age
  • intensive care unit
  • depressive symptoms
  • hepatitis b virus
  • single cell
  • working memory
  • neural network